Antisense & RNAi Therapeutics Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAntisense & RNAi Therapeutics Market?
The increasing incidences of coronary artery diseases, neurodegenerative conditions, and infectious diseases are expected to fuel the demand in the antisense & RNAi therapeutics market. Gene silencing techniques, such as RNA interference and antisense oligonucleotides, are employed for treating a variety of neurodegenerative diseases by fixing faulty genes. For example, as per the American Heart Association’s report in January 2024, a US-based entity, the age-adjusted death rate due to cardiovascular diseases rose to 233.3 per 100,000, marking a 4.0% increase from the previous year. Consequently, the rising occurrence of numerous neurodegenerative and infectious diseases is predicted to propel the antisense & RNAi therapeutics market’s growth.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
#What Long-Term Growth Rate is Expected for theAntisense & RNAi Therapeutics Market Between 2025 and 2034?
The dimension of the antisense & RNAi therapeutics market has seen swift expansion in the recent past. The market, which stands at $1.75 billion in 2024, is projected to elevate to $1.94 billion in 2025, showing a compound annual growth rate (CAGR) of 11.2%. The historical growth trajectory is tied to factors such as an upsurge in funding, technological advances, an increase in healthcare spending, a fast-rising aged population, and the economic advancement of emerging markets.
The market size of antisense & RNAi therapeutics is projected to witness substantial growth in the coming years. The market is estimated to balloon to $3.18 billion in 2029 with a compound annual growth rate (CAGR) of 13.1%. The expected growth during the forecast period is due to factors such as increased access to healthcare, a rise in cancer cases, and a growing demand for antisense and RNAi therapeutics amid the COVID-19 pandemic. Key trends during the forecast period will mainly center on the dedicated research and development of RNA therapeutics for rare diseases, adoption of nanoparticles, advancement of novel and enhanced antisense and RNAi therapeutics, and strategic partnerships with other firms to foster product innovation and revenue growth.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3389
What Are the Current Market Growth and Trends in theAntisense & RNAi Therapeutics Market That Industry Players Should Watch?
Prominent corporations engaged in the antisense & RNAi therapeutics market are adopting strategic measures such as collaborations and alliances to remain viable in the escalating competitive environment. Strategic collaborations consist of two or more organizations collaboratively working on a shared aim or objective. For instance, in January 2023, a partnership was forged between Orbit Discovery Limited, a U.S.-based provider of peptide discovery services, and SanegeneBio Inc., a U.K.-based corporation focused on creating innovative RNAi-based drugs, to aid in the identification of tissue-specific delivery of RNA therapeutics for efficient gene knockdown, with the end goal of crafting a range of advanced RNAi therapeutics. This partnership includes hit identification and internalization studies using cells, with SanegeneBio acquiring the privilege to further refine hits garnered from the screening procedures, optimized using Orbit’s exclusive technology designed for swift peptide lead discovery. Orbit Discovery’s distinct peptide display engine facilitates screening of sizable peptide libraries, thus expediting the discovery of suitable peptide leads based on affinity and functional screens.
What Are the Major Market Players Making an Impact on theAntisense & RNAi Therapeutics Market Growth?
Major companies operating in the antisense & RNAi therapeutics market include Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Moderna Inc., Sanofi S.A., Dicerna Pharmaceuticals Inc., Arbutus Biopharma Corporation, Acuitas Therapeutics, Adhera Therapeutics Inc., EdiGene Inc., Sirnaomics Inc., Suzhou Ribo Life Science Co. Ltd, Biocon Limited, Quark Pharmaceuticals, GlaxoSmithKline Plc, Shanghai Junshi Biosciences Co. Ltd., AstraZeneca, Benitec Biopharma Limited, Silence Therapeutics, Dynacure, CN Bio Innovations, Sarepta Therapeutics, Mallinckrodt, Regeneron Pharmaceuticals Inc., Alcyone Lifesciences Inc., Bio-Path Holdings Inc, Calando Pharmaceuticals, Enzon Pharmaceuticals Inc, Celnova Pharma, Pfizer Inc., Taiba Pharma, Gen Ilaç ve Saglik Ürünleri A.S., Egypt Otsuka Pharmaceutical
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Antisense & RNAi Therapeutics Market Driving Opportunities and Innovations?
The antisense & RNAi therapeutics market covered in this report is segmented –
1) By Technology: RNA Interference, Antisense RNA
2) By Route Of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), Short Hairpin RNA (shRNA), Dicer-substrate siRNA, MicroRNA (miRNA) Based Therapeutics
2) By Antisense RNA: Antisense Oligonucleotides (ASOs), Morpholino Oligomers, Locked Nucleic Acids (LNAs), Gapmer Antisense Oligonucleotides
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3389&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAntisense & RNAi Therapeutics Market?# Market Expansion?
North America was the largest region in the antisense & RNAi therapeutics market in 2024. The regions covered in the antisense & RNAi therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Antisense & RNAi Therapeutics Market 2025, By The Business Research Company:
Anti-Hypertensive Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report
Neurodegenerative Disorder Therapeutics Global Market Report 2024
Biosimilar Hormones Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
